ArticleOncology letters2018

Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway.

Suolin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.